<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="336702">
  <stage>Registered</stage>
  <submitdate>16/04/2011</submitdate>
  <approvaldate>27/04/2011</approvaldate>
  <actrnumber>ACTRN12611000425998</actrnumber>
  <trial_identification>
    <studytitle>Effects of phytoestrogen supplementation in postmenopausal women with dry eye syndrome: A randomized clinical trial.</studytitle>
    <scientifictitle>Correlation between sex hormone levels and tear film osmolarity and qualitative and quantitative film lacrimal improvement in post menopausal women with dry eye syndrome treated with oral  supplementation of phytoestrogen.</scientifictitle>
    <utrn>U1111-1120-1990</utrn>
    <trialacronym>DES (dry eye syndrome)</trialacronym>
    <secondaryid>' Nil'</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>dry eye syndrome</healthcondition>
    <conditioncode>
      <conditioncode1>Eye</conditioncode1>
      <conditioncode2>Diseases / disorders of the eye</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Other</conditioncode1>
      <conditioncode2>Conditions of unknown or disputed aetiology (such as chronic fatigue syndrome/myalgic encephalomyelitis)</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Sixty-six postmenopausal women with dysfunctional tear syndrome (DTS) were enrolled in a randomized, double-blind, placebo-controlled,  cross-over study. Patient were divided into two groups (Group A and Group B) and treated respectively with Lacrisek ( alpha lipoic acid100mg,phytoestrogen 200mg, fish oil 240mg),Registered Trademark, tablets or placebo tablets, twice a day for  30 days. The two treatment periods were separated by a 30-day washout. Patients were examined on day 0 and day 30 of each period. Assessments included blood  levels of sex hormones, the Schirmer test for tear production, and measurement of tear osmolarity and tear film break-time (T-BUT).</interventions>
    <comparator>placebo twice a day, oral methylcellulose tablets</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: Other</interventioncode>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>to assess the efficacy of an oral phytoestrogen supplement in controlling the ocular symptoms of post-menopausal Assessments included blood  levels of sex hormones, the Schirmer test for tear production,  measurement of tear osmolarity and tear film break-time (T-BUT)</outcome>
      <timepoint>at baseline,at 30 day after intervention</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>To asses that improvement of tear film function is limited in time. We valued Schirmer test,T-BUT (tear film break-up time), Tear osmolarty after 30 days after discontinuation of theraphy with Lacrisek.</outcome>
      <timepoint>after 30 day of intervention</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>menopause and severe dry eye syndrome.
Dry eye syndrome is defined as a multifactorial disorder caused by one chronic inflammatory status due to tear film disequilibrium, main symptoms are: photophobia, visual disturbance, extraneous body sensation, difficulties in eye opening at the morning.</inclusivecriteria>
    <inclusiveminage>48</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Hypersensitivity to one of components of the phytoestrogen supplement being tested, autoimmune disease, and current use of topical anti-inflammatory and/or antibiotic eye therapy</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Computerizated randomization</concealment>
    <sequence>Simple randomization by using a randomizated table created by computer software.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Crossover</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 4</phase>
    <anticipatedstartdate>1/09/2009</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>66</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Completed</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Italy</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Government body</primarysponsortype>
    <primarysponsorname>ministry of education university and research</primarysponsorname>
    <primarysponsoraddress>viale trastevere 76 roma 00100</primarysponsoraddress>
    <primarysponsorcountry>Italy</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>"sapienza"</fundingname>
      <fundingaddress>via di grottarossa 1035-1039
00189 Rome</fundingaddress>
      <fundingcountry>Italy</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The aims of our study were to evaluate the correlation between sex hormone levels and tear film osmolarity in postmenopausal women and to assess the efficacy of an oral phytoestrogen supplement in controlling the ocular symptoms of post-menopausal dysfunctional tear syndrome (DTS).</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Vittorio Emanuele University Catania</ethicname>
      <ethicaddress>via s.Sofia 78 95123 Catania</ethicaddress>
      <ethicapprovaldate>1/06/2009</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Italy</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Iacovello Daniela</name>
      <address>via di grottarossa 1035-1039
00189 Rome</address>
      <phone>+39-3494682907</phone>
      <fax>+39-06-33776602</fax>
      <email>iacosmile@alice.it</email>
      <country>Italy</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Iacovello Daniela</name>
      <address>via di grottarossa 1035-1039
00189 Rome</address>
      <phone>+39-3494682907</phone>
      <fax>+39-06-33776602</fax>
      <email>iacosmile@alice.it</email>
      <country>Italy</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Scuderi Gianluca</name>
      <address>via di grottarossa 1035-1039
00189 Rome</address>
      <phone>+39-3366240391</phone>
      <fax>+39-06-33776602</fax>
      <email>gianluca.scuderi@uniroma1.it</email>
      <country>Italy</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>